Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	olfactory receptor activity	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	6.34e-05	431	121	11	GO:0004984
GeneOntologyMolecularFunction	sodium ion binding	SCN1A SCN2A SCN3A	7.52e-05	14	121	3	GO:0031402
GeneOntologyMolecularFunction	(d)CMP kinase activity	CMPK1 AK8	2.17e-04	4	121	2	GO:0004127
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCB5 CFTR ABCA10 TAP1	2.20e-04	49	121	4	GO:0140359
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR4K2 OR6C74 OR2C3 ADGRB3 OR5H15 TSHR OR6B3 P2RY4 OR5H8 OR6Y1 GPR171 OR51G1 OR5H1 OR6B2 OR51B4	2.96e-04	884	121	15	GO:0004930
GeneOntologyMolecularFunction	nucleoside monophosphate kinase activity	CMPK1 AK8 CARD11	3.52e-04	23	121	3	GO:0050145
GeneOntologyMolecularFunction	voltage-gated sodium channel activity	SCN1A SCN2A SCN3A	5.10e-04	26	121	3	GO:0005248
GeneOntologyMolecularFunction	alkali metal ion binding	SCN1A SCN2A SCN3A	5.10e-04	26	121	3	GO:0031420
GeneOntologyBiologicalProcess	regulation of T-helper 1 cell cytokine production	SLAMF1 XCL2 XCL1	1.69e-05	9	123	3	GO:2000554
GeneOntologyBiologicalProcess	positive regulation of T-helper 1 cell cytokine production	SLAMF1 XCL2 XCL1	1.69e-05	9	123	3	GO:2000556
GeneOntologyBiologicalProcess	mature natural killer cell chemotaxis	XCL2 XCL1	3.53e-05	2	123	2	GO:0035782
GeneOntologyBiologicalProcess	T-helper 1 cell cytokine production	SLAMF1 XCL2 XCL1	4.38e-05	12	123	3	GO:0035744
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 SCN1A OR5H8 PTPRQ OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	4.53e-05	582	123	13	GO:0050906
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	5.64e-05	432	123	11	GO:0050911
GeneOntologyBiologicalProcess	positive regulation of CD4-positive, alpha-beta T cell proliferation	XCL2 CARD11 XCL1	5.67e-05	13	123	3	GO:2000563
GeneOntologyBiologicalProcess	regulation of B cell chemotaxis	XCL2 XCL1	1.05e-04	3	123	2	GO:2000537
GeneOntologyBiologicalProcess	positive regulation of B cell chemotaxis	XCL2 XCL1	1.05e-04	3	123	2	GO:2000538
GeneOntologyBiologicalProcess	positive regulation of immunoglobulin production in mucosal tissue	XCL2 XCL1	1.05e-04	3	123	2	GO:2000558
GeneOntologyBiologicalProcess	regulation of immunoglobulin production in mucosal tissue	XCL2 XCL1	1.05e-04	3	123	2	GO:2000557
GeneOntologyBiologicalProcess	sensory perception of smell	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	1.08e-04	465	123	11	GO:0007608
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization involved in mitosis	TUBG2 RAB11A TUBG1 PKHD1 ARHGEF2 KIF11 KPNB1	1.32e-04	187	123	7	GO:1902850
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	1.57e-04	485	123	11	GO:0050907
GeneOntologyBiologicalProcess	positive regulation of T-helper 1 type immune response	SLAMF1 XCL2 XCL1	2.19e-04	20	123	3	GO:0002827
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	3.05e-04	524	123	11	GO:0009593
GeneOntologyBiologicalProcess	positive regulation of thymocyte migration	XCL2 XCL1	3.49e-04	5	123	2	GO:2000412
GeneOntologyBiologicalProcess	immunoglobulin production in mucosal tissue	XCL2 XCL1	3.49e-04	5	123	2	GO:0002426
GeneOntologyCellularComponent	voltage-gated sodium channel complex	SCN1A SCN2A SCN3A	1.27e-04	17	123	3	GO:0001518
GeneOntologyCellularComponent	gamma-tubulin complex	TUBG2 TUBG1 BRCA1	2.45e-04	21	123	3	GO:0000930
GeneOntologyCellularComponent	P-body	SAMD4B UPF1 IGF2BP1 IGF2BP3 MEX3A	3.43e-04	102	123	5	GO:0000932
GeneOntologyCellularComponent	eukaryotic translation initiation factor 2 complex	EIF2S3B EIF2S3	5.07e-04	6	123	2	GO:0005850
GeneOntologyCellularComponent	sodium channel complex	SCN1A SCN2A SCN3A	6.50e-04	29	123	3	GO:0034706
MousePheno	abnormal small intestinal villus morphology	PDGFA CFTR IGF2BP1 MEX3A BRCA1	2.11e-05	53	89	5	MP:0008108
MousePheno	bile duct epithelium hyperplasia	CFTR PKHD1	4.01e-05	2	89	2	MP:0014233
Domain	Na_trans_cytopl	SCN1A SCN2A SCN3A	4.85e-06	6	118	3	PF11933
Domain	Na_trans_cytopl	SCN1A SCN2A SCN3A	4.85e-06	6	118	3	IPR024583
Domain	Na_channel_asu	SCN1A SCN2A SCN3A	2.86e-05	10	118	3	IPR001696
Domain	Na_trans_assoc	SCN1A SCN2A SCN3A	2.86e-05	10	118	3	IPR010526
Domain	Na_trans_assoc	SCN1A SCN2A SCN3A	2.86e-05	10	118	3	PF06512
Domain	Chemokine_XCL1/XCL2	XCL2 XCL1	3.96e-05	2	118	2	IPR008105
Domain	Gamma_tubulin	TUBG2 TUBG1	3.96e-05	2	118	2	IPR002454
Domain	DH_1	ARHGEF28 TRIO ARHGEF18 ARHGEF2 PREX1	4.85e-05	63	118	5	PS00741
Domain	RhoGEF	ARHGEF28 TRIO ARHGEF18 ARHGEF2 PREX1	7.01e-05	68	118	5	SM00325
Domain	-	CMPK1 LONP2 ZGRF1 ABCB5 CFTR RAB11A UPF1 ABCA10 AK8 EIF2S3 RAD54B CARD11 TAP1 DNAH9 HYDIN	7.21e-05	746	118	15	3.40.50.300
Domain	RhoGEF	ARHGEF28 TRIO ARHGEF18 ARHGEF2 PREX1	8.06e-05	70	118	5	PF00621
Domain	DH_2	ARHGEF28 TRIO ARHGEF18 ARHGEF2 PREX1	8.06e-05	70	118	5	PS50010
Domain	P-loop_NTPase	CMPK1 LONP2 ZGRF1 ABCB5 CFTR RAB11A UPF1 ABCA10 AK8 EIF2S3 RAD54B CARD11 TAP1 DNAH9 HYDIN KIF11	8.61e-05	848	118	16	IPR027417
Domain	DH-domain	ARHGEF28 TRIO ARHGEF18 ARHGEF2 PREX1	8.63e-05	71	118	5	IPR000219
Domain	-	ARHGEF28 TRIO ARHGEF18 ARHGEF2 PREX1	8.63e-05	71	118	5	1.20.900.10
Domain	ABC_transporter_CS	ABCB5 CFTR ABCA10 TAP1	1.41e-04	42	118	4	IPR017871
Domain	Olfact_rcpt	OR4K2 OR6C74 OR2C3 OR5H15 OR6B3 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	1.97e-04	393	118	10	IPR000725
Domain	VPS13_C	VPS13C VPS13B	2.36e-04	4	118	2	PF16909
Domain	SHR-BD	VPS13C VPS13B	2.36e-04	4	118	2	IPR009543
Domain	VPS13_C	VPS13C VPS13B	2.36e-04	4	118	2	IPR031645
Domain	SHR-BD	VPS13C VPS13B	2.36e-04	4	118	2	PF06650
Domain	ABC_tran	ABCB5 CFTR ABCA10 TAP1	2.38e-04	48	118	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCB5 CFTR ABCA10 TAP1	2.38e-04	48	118	4	PS50893
Domain	ABC_TRANSPORTER_1	ABCB5 CFTR ABCA10 TAP1	2.58e-04	49	118	4	PS00211
Domain	ABC_transporter-like	ABCB5 CFTR ABCA10 TAP1	2.79e-04	50	118	4	IPR003439
Domain	AAA+_ATPase	LONP2 ABCB5 CFTR ABCA10 TAP1 DNAH9	3.07e-04	144	118	6	IPR003593
Domain	AAA	LONP2 ABCB5 CFTR ABCA10 TAP1 DNAH9	3.07e-04	144	118	6	SM00382
Domain	GPCR_Rhodpsn_7TM	OR4K2 OR6C74 OR2C3 OR5H15 TSHR OR6B3 P2RY4 OR6Y1 GPR171 OR51G1 OR5H1 OR6B2 OR51B4	3.18e-04	670	118	13	IPR017452
Domain	7tm_1	OR4K2 OR6C74 OR2C3 OR5H15 TSHR OR6B3 P2RY4 OR6Y1 GPR171 OR51G1 OR5H1 OR6B2 OR51B4	3.51e-04	677	118	13	PF00001
Domain	ATG_C	VPS13C VPS13B	3.91e-04	5	118	2	PF09333
Domain	Autophagy-rel_C	VPS13C VPS13B	3.91e-04	5	118	2	IPR015412
Domain	G_PROTEIN_RECEP_F1_1	OR4K2 OR6C74 OR2C3 OR5H15 TSHR OR6B3 P2RY4 OR6Y1 GPR171 OR51G1 OR5H1 OR6B2 OR51B4	3.92e-04	685	118	13	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR4K2 OR6C74 OR2C3 OR5H15 TSHR OR6B3 P2RY4 OR6Y1 GPR171 OR51G1 OR5H1 OR6B2 OR51B4	4.26e-04	691	118	13	PS50262
Domain	GPCR_Rhodpsn	OR4K2 OR6C74 OR2C3 OR5H15 TSHR OR6B3 P2RY4 OR6Y1 GPR171 OR51G1 OR5H1 OR6B2 OR51B4	4.32e-04	692	118	13	IPR000276
Domain	ABC_membrane	ABCB5 CFTR TAP1	4.52e-04	24	118	3	PF00664
Domain	ICAM_VCAM_N	ICAM1 VCAM1	5.84e-04	6	118	2	IPR003987
Domain	ABC_TM1F	ABCB5 CFTR TAP1	7.18e-04	28	118	3	PS50929
Domain	ABC1_TM_dom	ABCB5 CFTR TAP1	7.18e-04	28	118	3	IPR011527
Domain	VPS13_N	VPS13C VPS13B	1.08e-03	8	118	2	IPR026854
Domain	ADENYLATE_KINASE	CMPK1 AK8	1.08e-03	8	118	2	PS00113
Domain	Chorein_N	VPS13C VPS13B	1.08e-03	8	118	2	PF12624
Domain	Transglut_N	TGM5 TGM2	1.38e-03	9	118	2	PF00868
Domain	TRANSGLUTAMINASES	TGM5 TGM2	1.38e-03	9	118	2	PS00547
Domain	Transglutaminase_N	TGM5 TGM2	1.38e-03	9	118	2	IPR001102
Domain	Transglut_C	TGM5 TGM2	1.38e-03	9	118	2	PF00927
Domain	-	TGM5 TGM2	1.38e-03	9	118	2	3.90.260.10
Domain	Gln_gamma-glutamylTfrase_euk	TGM5 TGM2	1.38e-03	9	118	2	IPR023608
Domain	Transglutaminase_AS	TGM5 TGM2	1.38e-03	9	118	2	IPR013808
Domain	Adenylat/UMP-CMP_kin	CMPK1 AK8	1.72e-03	10	118	2	IPR000850
Domain	Transglutaminase_C	TGM5 TGM2	1.72e-03	10	118	2	IPR008958
Domain	IQ	DCAF6 SCN1A SCN2A SCN3A	1.73e-03	81	118	4	SM00015
Domain	KH_1	IGF2BP1 IGF2BP3 MEX3A	1.77e-03	38	118	3	PF00013
Domain	GDS_CDC24_CS	TRIO ARHGEF2 PREX1	1.90e-03	39	118	3	IPR001331
Domain	-	IGF2BP1 IGF2BP3 MEX3A	1.90e-03	39	118	3	3.30.1370.10
Domain	KH	IGF2BP1 IGF2BP3 MEX3A	2.05e-03	40	118	3	SM00322
Domain	KH_dom	IGF2BP1 IGF2BP3 MEX3A	2.05e-03	40	118	3	IPR004087
Domain	TGc	TGM5 TGM2	2.10e-03	11	118	2	SM00460
Domain	Transglut_core	TGM5 TGM2	2.10e-03	11	118	2	PF01841
Domain	Transglutaminase-like	TGM5 TGM2	2.10e-03	11	118	2	IPR002931
Domain	KH_TYPE_1	IGF2BP1 IGF2BP3 MEX3A	2.36e-03	42	118	3	PS50084
Domain	IQ_motif_EF-hand-BS	DCAF6 SCN1A SCN2A SCN3A	2.55e-03	90	118	4	IPR000048
Domain	KH_dom_type_1	IGF2BP1 IGF2BP3 MEX3A	2.70e-03	44	118	3	IPR004088
Domain	IQ	DCAF6 SCN1A SCN2A SCN3A	2.87e-03	93	118	4	PS50096
Domain	Channel_four-helix_dom	SCN1A SCN2A SCN3A	5.61e-03	57	118	3	IPR027359
Domain	-	SCN1A SCN2A SCN3A	5.61e-03	57	118	3	1.20.120.350
Domain	C1_1	ARHGEF28 ARAF ARHGEF2	5.61e-03	57	118	3	PF00130
Domain	Ion_trans_dom	RYR3 SCN1A SCN2A SCN3A	5.93e-03	114	118	4	IPR005821
Domain	Ion_trans	RYR3 SCN1A SCN2A SCN3A	5.93e-03	114	118	4	PF00520
Pubmed	SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.	SCN1A SCN2A SCN3A	4.42e-08	3	124	3	23859570
Pubmed	Sodium channels SCN1A, SCN2A and SCN3A in familial autism.	SCN1A SCN2A SCN3A	4.42e-08	3	124	3	12610651
Pubmed	Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.	SCN1A SCN2A SCN3A	4.42e-08	3	124	3	18784617
Pubmed	Characterization of 5' untranslated regions of the voltage-gated sodium channels SCN1A, SCN2A, and SCN3A and identification of cis-conserved noncoding sequences.	SCN1A SCN2A SCN3A	4.42e-08	3	124	3	17544618
Pubmed	Early expression of sodium channel transcripts and sodium current by cajal-retzius cells in the preplate of the embryonic mouse neocortex.	SCN1A SCN2A SCN3A	4.42e-08	3	124	3	14973256
Pubmed	Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.	SCN1A SCN2A SCN3A	1.76e-07	4	124	3	17537961
Pubmed	Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population.	SCN1A SCN2A SCN3A	1.76e-07	4	124	3	35801810
Pubmed	Sodium channel expression and transcript variation in the developing brain of human, Rhesus monkey, and mouse.	SCN1A SCN2A SCN3A	1.76e-07	4	124	3	35031483
Pubmed	Abnormal changes in voltage-gated sodium channels subtypes NaV1.1, NaV1.2, NaV1.3, NaV1.6 and CaM/CaMKII pathway in low-grade astrocytoma.	SCN1A SCN2A SCN3A	1.76e-07	4	124	3	29578003
Pubmed	Use of recombinant inbred strains for studying genetic determinants of responses to alcohol.	SCN1A SCN2A SCN3A	1.76e-07	4	124	3	8974318
Pubmed	Cell cycle-related kinase is a crucial regulator for ciliogenesis and Hedgehog signaling in embryonic mouse lung development.	IFT140 TUBG2 TUBG1 IFT122 DNAH9	3.16e-07	40	124	5	32317081
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	MANBA TUBG2 CPT1A ARAF TUBG1 TGM2 IGF2BP1 IGF2BP3 MGAT3 SUSD1 ARHGEF2 KIF11 KPNB1	3.21e-07	613	124	13	22268729
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR4K2 OR6C74 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	4.26e-07	340	124	10	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR4K2 OR6C74 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	4.26e-07	340	124	10	11802173
Pubmed	Three brain sodium channel alpha-subunit genes are clustered on the proximal segment of mouse chromosome 2.	SCN1A SCN2A SCN3A	4.40e-07	5	124	3	1679748
Pubmed	A new sodium channel alpha-subunit gene (Scn9a) from Schwann cells maps to the Scn1a, Scn2a, Scn3a cluster of mouse chromosome 2.	SCN1A SCN2A SCN3A	4.40e-07	5	124	3	8812438
Pubmed	Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.	SCN1A SCN2A SCN3A	4.40e-07	5	124	3	24337656
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR4K2 OR6C74 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	4.61e-07	343	124	10	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR4K2 OR6C74 OR5H15 OR6B3 OR5H8 OR6Y1 OR51G1 OR5H1 OR6B2 OR51B4	4.99e-07	346	124	10	14611657
Pubmed	A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain.	SCN1A SCN2A SCN3A	8.78e-07	6	124	3	23652591
Pubmed	Development of Ependymal and Postnatal Neural Stem Cells and Their Origin from a Common Embryonic Progenitor.	TUBG2 TUBG1 VCAM1	8.78e-07	6	124	3	30970247
Pubmed	Mammalian RanBP1 regulates centrosome cohesion during mitosis.	TUBG2 TUBG1 KIF11	1.53e-06	7	124	3	12840069
Pubmed	International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.	SCN1A SCN2A SCN3A	3.66e-06	9	124	3	16382098
Pubmed	Expression pattern of neuronal and skeletal muscle voltage-gated Na+ channels in the developing mouse heart.	SCN1A SCN2A SCN3A	3.66e-06	9	124	3	15746173
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ARHGEF28 LONP2 SAMD4B RALGAPB ARAF TGM2 EIF2S3 RAD54B ELP2 IFT122 ARHGEF2 EXOC4	3.90e-06	650	124	12	38777146
Pubmed	Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10.	CFTR SLAMF1 XCL2 XCL1	4.49e-06	31	124	4	15921521
Pubmed	Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage.	TUBG2 TUBG1 DNAH9 HYDIN	7.40e-06	35	124	4	37890489
Pubmed	Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice.	SCN1A SCN2A SCN3A	9.51e-06	12	124	3	30175250
Pubmed	Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.	SCN1A SCN2A SCN3A	9.51e-06	12	124	3	8169823
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	KRT17 LONP2 NUDT21 RAB11A USP24 EIF2S3B UPF1 CPT1A PPWD1 TUBG1 KCTD6 IGF2BP1 IGF2BP3 EIF2S3 ARHGEF2 KIF11 KPNB1	1.18e-05	1415	124	17	28515276
Pubmed	Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2.	SCN1A SCN2A SCN3A	1.23e-05	13	124	3	15123669
Pubmed	Structure and expression of two highly related genes encoding SCM-1/human lymphotactin.	XCL2 XCL1	1.26e-05	2	124	2	8849694
Pubmed	Adhesion molecule expression and ventricular remodeling in chronic rheumatic heart disease: a cause or effect in the disease progression--a pilot study.	ICAM1 VCAM1	1.26e-05	2	124	2	22001052
Pubmed	TG2 regulates the heat-shock response by the post-translational modification of HSF1.	CFTR TGM2	1.26e-05	2	124	2	29752334
Pubmed	Clcn2 encodes the hyperpolarization-activated chloride channel in the ducts of mouse salivary glands.	CFTR CLCN2	1.26e-05	2	124	2	18801913
Pubmed	Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2-->q24.3 in a girl with autistic features and developmental delay.	SCN2A SCN3A	1.26e-05	2	124	2	20346423
Pubmed	BRCA1 is associated with the centrosome during mitosis.	TUBG1 BRCA1	1.26e-05	2	124	2	9789027
Pubmed	Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2.	ICAM1 VCAM1	1.26e-05	2	124	2	25990052
Pubmed	Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.	ICAM1 VCAM1	1.26e-05	2	124	2	17560459
Pubmed	Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice.	SCN1A SCN2A	1.26e-05	2	124	2	10827969
Pubmed	Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms.	ICAM1 VCAM1	1.26e-05	2	124	2	19597294
Pubmed	Correlation between the levels of circulating adhesion molecules and atherosclerosis in type-2 diabetic normotensive patients: circulating adhesion molecules and atherosclerosis.	ICAM1 VCAM1	1.26e-05	2	124	2	19717975
Pubmed	Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.	SCN1A SCN2A	1.26e-05	2	124	2	19694741
Pubmed	Cloning of ClC-2 chloride channel from murine duodenum and its presence in CFTR knockout mice.	CFTR CLCN2	1.26e-05	2	124	2	10524221
Pubmed	Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus.	SCN2A SCN3A	1.26e-05	2	124	2	11245985
Pubmed	Association of soluble cell adhesion molecules with ankle-brachial index in a biethnic cohort of predominantly hypertensive individuals.	ICAM1 VCAM1	1.26e-05	2	124	2	18787016
Pubmed	[Exploration of the levels and significance of serum s C5b-9, s VCAM-1, s ICZM-1 in children wit asthma].	ICAM1 VCAM1	1.26e-05	2	124	2	15059493
Pubmed	Expression of functional ICAM-1 and VCAM-1 adhesion molecules by an immortalized epithelial cell clone derived from the small intestine.	ICAM1 VCAM1	1.26e-05	2	124	2	9015189
Pubmed	Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes.	ICAM1 VCAM1	1.26e-05	2	124	2	25857767
Pubmed	Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease.	CFTR PKHD1	1.26e-05	2	124	2	34329764
Pubmed	Differential expression of two sodium channel subtypes in human brain.	SCN1A SCN2A	1.26e-05	2	124	2	1317301
Pubmed	An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium.	ICAM1 VCAM1	1.26e-05	2	124	2	17116732
Pubmed	Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy.	SCN2A SCN3A	1.26e-05	2	124	2	23016767
Pubmed	Whole gene duplication of SCN2A and SCN3A is associated with neonatal seizures and a normal intellectual development.	SCN2A SCN3A	1.26e-05	2	124	2	27153334
Pubmed	Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A.	SCN1A SCN3A	1.26e-05	2	124	2	24990319
Pubmed	Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models.	CFTR CLCN2	1.26e-05	2	124	2	15007059
Pubmed	Adhesion molecules: key players in Mesenchymal stem cell-mediated immunosuppression.	ICAM1 VCAM1	1.26e-05	2	124	2	20935502
Pubmed	Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series.	SCN1A SCN2A	1.26e-05	2	124	2	31439038
Pubmed	Renal expression of adhesion molecules in anca-associated disease.	ICAM1 VCAM1	1.26e-05	2	124	2	18574676
Pubmed	Relationship of Polymorphism of Adhesion Molecules VCAM-1 and ICAM-1 with Preeclampsia.	ICAM1 VCAM1	1.26e-05	2	124	2	32161015
Pubmed	Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human endometrial stromal and epithelial cells is regulated by interferon-gamma but not iron.	ICAM1 VCAM1	1.26e-05	2	124	2	17962718
Pubmed	Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.	ICAM1 VCAM1	1.26e-05	2	124	2	20405289
Pubmed	Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction.	ICAM1 VCAM1	1.26e-05	2	124	2	26216937
Pubmed	MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages.	TUBG2 TUBG1	1.26e-05	2	124	2	17442887
Pubmed	Differentiating Stages of Bipolar and Unipolar Depression-The Possible Role of sICAM-1 and sVCAM-1.	ICAM1 VCAM1	1.26e-05	2	124	2	39056795
Pubmed	Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice.	ICAM1 VCAM1	1.26e-05	2	124	2	14512165
Pubmed	[Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer].	BRCA1 RAD54B	1.26e-05	2	124	2	17405295
Pubmed	Ethyl gallate isolated from Pistacia integerrima Linn. inhibits cell adhesion molecules by blocking AP-1 transcription factor.	ICAM1 VCAM1	1.26e-05	2	124	2	21843619
Pubmed	Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.	XCL2 XCL1	1.26e-05	2	124	2	9834111
Pubmed	[Associations of ICAM1 gene and VCAM1 promoter polymorphisms with transplanted kidney function].	ICAM1 VCAM1	1.26e-05	2	124	2	22593994
Pubmed	Overexpression of γ-tubulin in non-small cell lung cancer.	TUBG2 TUBG1	1.26e-05	2	124	2	22806905
Pubmed	Inhibitory effects of clotrimazole on TNF-alpha-induced adhesion molecule expression and angiogenesis.	ICAM1 VCAM1	1.26e-05	2	124	2	19407978
Pubmed	Lysophosphatidylcholine promotes intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells via an orphan G protein receptor 2-mediated signaling pathway.	ICAM1 VCAM1	1.26e-05	2	124	2	34346841
Pubmed	Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.	ICAM1 VCAM1	1.26e-05	2	124	2	15153560
Pubmed	Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A.	SCN1A SCN2A	1.26e-05	2	124	2	15249644
Pubmed	Mapping of a FEB3 homologous febrile seizure locus on mouse chromosome 2 containing candidate genes Scn1a and Scn3a.	SCN1A SCN3A	1.26e-05	2	124	2	27690330
Pubmed	T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production.	XCL2 XCL1	1.26e-05	2	124	2	22528127
Pubmed	Serum soluble ICAM-1, VCAM-1, L-selectin, and P-selectin levels as markers of infection and their relation to clinical severity in neonatal sepsis.	ICAM1 VCAM1	1.26e-05	2	124	2	17564956
Pubmed	Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.	XCL2 XCL1	1.26e-05	2	124	2	25497737
Pubmed	Circulating adhesion molecules and arterial stiffness.	ICAM1 VCAM1	1.26e-05	2	124	2	25784313
Pubmed	Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis.	XCL2 XCL1	1.26e-05	2	124	2	19097989
Pubmed	Curcumin attenuates TNF-α-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells.	ICAM1 VCAM1	1.26e-05	2	124	2	22183741
Pubmed	HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.	ICAM1 VCAM1	1.26e-05	2	124	2	17657162
Pubmed	The impact of ICAM1 and VCAM1 gene polymorphisms on chronic allograft nephropathy and transplanted kidney function.	ICAM1 VCAM1	1.26e-05	2	124	2	23953534
Pubmed	Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects.	ICAM1 VCAM1	1.26e-05	2	124	2	21804483
Pubmed	Expression of the retinoic acid-metabolizing enzymes RALDH2 and CYP26b1 during mouse postnatal testis development.	CYP26B1 ALDH1A2	1.26e-05	2	124	2	18478160
Pubmed	Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.	CFTR CLCN2	1.26e-05	2	124	2	18805957
Pubmed	Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome.	SCN1A SCN3A	1.26e-05	2	124	2	23965409
Pubmed	Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo.	XCL2 XCL1	1.26e-05	2	124	2	9029087
Pubmed	Identification of a gamma-tubulin-binding domain in BRCA1.	TUBG1 BRCA1	1.26e-05	2	124	2	11691781
Pubmed	Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: role of CD4 and chemokine coreceptors.	ICAM1 VCAM1	1.26e-05	2	124	2	14691297
Pubmed	Allocation of gamma-tubulin between oocyte cortex and meiotic spindle influences asymmetric cytokinesis in the mouse oocyte.	TUBG2 TUBG1	1.26e-05	2	124	2	17287496
Pubmed	Nuclear transit of human zipcode-binding protein IMP1.	IGF2BP1 IGF2BP3	1.26e-05	2	124	2	12921532
Pubmed	The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis.	IGF2BP1 IGF2BP3	1.26e-05	2	124	2	11992722
Pubmed	Serum VCAM-1 and ICAM-1 measurement assists for MACE risk estimation in ST-segment elevation myocardial infarction patients.	ICAM1 VCAM1	1.26e-05	2	124	2	36045604
Pubmed	Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.	ICAM1 VCAM1	1.26e-05	2	124	2	17347482
Pubmed	SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.	SCN1A SCN2A	1.26e-05	2	124	2	30693367
Pubmed	Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse.	ICAM1 VCAM1	1.26e-05	2	124	2	9029122
Pubmed	The systemic exercise-released chemokine lymphotactin/XCL1 modulates in vitro adult hippocampal precursor cell proliferation and neuronal differentiation.	XCL2 XCL1	1.26e-05	2	124	2	31413355
Pubmed	Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia.	ICAM1 VCAM1	1.26e-05	2	124	2	26679764
Interaction	FBXO6 interactions	TRHDE COL12A1 MANBA TUBG2 ICAM1 CPT1A ARAF TUBG1 TGM2 IGF2BP1 IGF2BP3 MGAT3 SUSD1 ARHGEF2 KIF11 KPNB1	2.49e-06	717	113	16	int:FBXO6
Interaction	ANXA1 interactions	CFTR RAB11A ARAF TGM2 IGF2BP1 IGF2BP3 BRCA1 USP48 VCAM1 KIF11	8.79e-06	306	113	10	int:ANXA1
Interaction	LINC01587 interactions	CLTCL1 VPS13C RALGAPB KIF11	1.08e-05	25	113	4	int:LINC01587
Interaction	RNF19A interactions	TUBG2 NUDT21 TUBG1 MEX3A	1.49e-05	27	113	4	int:RNF19A
Interaction	TRIO interactions	TRIO RAB11A EIF2S3B MEX3A BRCA1 EIF2S3	3.44e-05	109	113	6	int:TRIO
Cytoband	Ensembl 112 genes in cytogenetic band chr3q11	OR5H15 OR5H8 OR5H1	4.31e-04	54	124	3	chr3q11
Cytoband	17q21	TUBG2 TUBG1 BRCA1	6.78e-04	63	124	3	17q21
Cytoband	2q24.3	SCN1A SCN2A	8.47e-04	16	124	2	2q24.3
Cytoband	7p22	PDGFA CARD11	1.33e-03	20	124	2	7p22
Cytoband	3q12.1	OR5H15 OR5H8	1.47e-03	21	124	2	3q12.1
Cytoband	10q24.1	CC2D2B KIF11	1.61e-03	22	124	2	10q24.1
Cytoband	Ensembl 112 genes in cytogenetic band chr17q21	KRT17 TUBG2 TUBG1 IGF2BP1 BRCA1 KPNB1	1.86e-03	473	124	6	chr17q21
Cytoband	1q24.2	DCAF6 XCL2	2.61e-03	28	124	2	1q24.2
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN1A SCN2A SCN3A	9.81e-06	9	90	3	1203
GeneFamily	Olfactory receptors, family 6	OR6C74 OR6B3 OR6Y1 OR6B2	1.20e-04	51	90	4	153
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO ARHGEF18 ARHGEF2 PREX1	3.27e-04	66	90	4	722
GeneFamily	Components of oligomeric golgi complex	COG2 COG8	6.73e-04	8	90	2	493
GeneFamily	Transglutaminases	TGM5 TGM2	8.62e-04	9	90	2	773
GeneFamily	UPF1 like RNA helicases	ZGRF1 UPF1	1.31e-03	11	90	2	1169
GeneFamily	ATP binding cassette subfamily B	ABCB5 TAP1	1.31e-03	11	90	2	806
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRM PTPRQ	4.84e-03	21	90	2	813
Coexpression	DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS	SIDT1 TSHR SLFN12L XCL2 CARD11 XCL1 KIF11	5.12e-06	145	121	7	M40278
CoexpressionAtlas	gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3	DSG2 SIDT1 AK8 TUBG1 IGF2BP1 IGF2BP3 BRCA1 SYTL3 RAD54B XCL1 KIF11	1.15e-05	419	110	11	GSM476664_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000	TRHDE CYP26B1 KRT17 CFTR ADGRB3 FREM1 SCN3A LSAMP CDH11 VCAM1	2.68e-05	377	110	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	MROH2A PON3 GASK1B FREM1 GREB1L TGM2 ALDH1A2 MEX3A GUCY1A2 SCN2A RAD54B CDH11 VCAM1 KIF11	4.61e-05	773	110	14	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	ZGRF1 SLAMF1 TGM2 IGF2BP1 IGF2BP3 MEX3A BRCA1 SUSD1 RAD54B KIF11	7.05e-05	423	110	10	GSM791126_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	MPEG1 IGF2BP1 IGF2BP3 SUSD1 KIF11	7.17e-05	83	110	5	GSM538348_100
CoexpressionAtlas	Myeloid Cells, MF.Sbcaps.SLN, CD11b+ CD169+ F4/80-, Lymph Node, avg-2	ARHGEF28 TRIO SIDT1 MPEG1 AK8 TGM2 SYTL3 XCL1 VCAM1	7.82e-05	345	110	9	GSM854324_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	MPEG1 IGF2BP1 IGF2BP3 SUSD1 KIF11	8.97e-05	87	110	5	GSM538350_100
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1	MPEG1 IGF2BP1 IGF2BP3 SUSD1 KIF11	9.48e-05	88	110	5	GSM538357_100
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	MPEG1 IGF2BP1 IGF2BP3 SUSD1 KIF11	1.00e-04	89	110	5	GSM538355_100
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	FREM1 GREB1L IGF2BP3 ALDH1A2 GUCY1A2 SCN2A CDH11	1.03e-04	207	110	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_100	FREM1 ALDH1A2 CDH11	1.04e-04	18	110	3	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_100
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000	PDGFA MROH2A CFTR TUBG1 ALDH1A2 MEX3A BRCA1 PTPRM SCN2A RAD54B LSAMP CDH11 KIF11	1.34e-04	749	110	13	gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlas	e10.5_Nasal_Pit_top-relative-expression-ranked_500_4	PDGFA SAMD4B	1.58e-04	4	110	2	Facebase_ST1_e10.5_Nasal_Pit_500_4
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	TRIO TUBG1 IGF2BP1 IGF2BP3 MEX3A BRCA1 DDA1 ARHGEF2 EXOC4 KPNB1	2.66e-04	498	110	10	gudmap_developingGonad_e11.5_testes_k5_1000
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1	ZGRF1 MPEG1 IGF2BP1 IGF2BP3 MEX3A BRCA1 SUSD1 RAD54B KIF11	3.28e-04	418	110	9	GSM538350_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	GASK1B FREM1 GREB1L IGF2BP1 IGF2BP3 ALDH1A2 GUCY1A2 SCN2A CDH11	3.28e-04	418	110	9	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2	ZGRF1 MPEG1 IGF2BP1 IGF2BP3 MEX3A BRCA1 SUSD1 RAD54B KIF11	3.34e-04	419	110	9	GSM538348_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1	ZGRF1 MPEG1 IGF2BP1 IGF2BP3 MEX3A BRCA1 SUSD1 RAD54B KIF11	3.51e-04	422	110	9	GSM538357_500
CoexpressionAtlas	B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2	ZGRF1 MPEG1 IGF2BP1 IGF2BP3 MEX3A BRCA1 SUSD1 RAD54B KIF11	3.51e-04	422	110	9	GSM538355_500
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1	COL12A1 CYP26B1 GASK1B TGM2 ALDH1A2 SCN3A CDH11 VCAM1	3.66e-04	336	110	8	ratio_EB_vs_SC_1000_K1
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	FREM1 GREB1L IGF2BP3 ALDH1A2 MEX3A GUCY1A2 SCN2A CDH11	3.73e-04	337	110	8	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_100	CFTR CDH11	3.94e-04	6	110	2	gudmap_kidney_P2_CapMes_Crym_k3_100
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	IGF2BP1 IGF2BP3 MEX3A BRCA1 SACS DDA1 ARHGEF2 KIF11 EXOC4 KPNB1	4.54e-04	533	110	10	gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
CoexpressionAtlas	DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000	IFT140 CFTR TSHR UPF1 FREM1 TGM5 GREB1L IGF2BP1 IGF2BP3 ALDH1A2 LSAMP IFT122 ARHGEF2	4.55e-04	850	110	13	gudmap_developingKidney_e11.5_metaneph mesench_1000
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2	KRT17 DSG2 PTPRQ VCAM1	4.81e-04	70	110	4	GSM777041_100
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE COL12A1 MROH2A CFTR TEX11 FREM1 RYR3 SCN2A PTPRQ PKHD1 DNAH9 HYDIN	1.48e-13	184	123	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE COL12A1 MROH2A CFTR TEX11 FREM1 RYR3 SCN2A PTPRQ PKHD1 DNAH9 HYDIN	1.48e-13	184	123	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE COL12A1 MROH2A CFTR TEX11 FREM1 RYR3 SCN2A PTPRQ PKHD1 DNAH9 HYDIN	1.48e-13	184	123	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE COL12A1 KCTD19 MROH2A CFTR FREM1 RYR3 PTPRQ PKHD1 DNAH9 HYDIN	8.89e-13	160	123	11	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE COL12A1 KCTD19 MROH2A CFTR FREM1 RYR3 PTPRQ PKHD1 DNAH9 HYDIN	8.89e-13	160	123	11	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE COL12A1 ADGRB3 FREM1 PTPRQ PKHD1 DNAH9 HYDIN	3.14e-08	175	123	8	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE ADGRB3 FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	6.44e-08	192	123	8	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE ADGRB3 FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	6.97e-08	194	123	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF28 ABCA10 AK8 IGF2BP1 ALDH1A2 XCL2 XCL1	2.14e-07	151	123	7	09405a450af3ea246d9685a6d3137dfaec80e9bf
ToppCell	390C-Lymphocytic-ILC\|390C / Donor, Lineage, Cell class and subclass (all cells)	COG2 ZGRF1 SLAMF1 ZNF587B XCL2 GPR171 XCL1	3.75e-07	164	123	7	b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f
ToppCell	CTRL-Lymphoid-T_cell_&_NK_cell\|CTRL / Disease state, Lineage and Cell class	SIDT1 SLAMF1 SLFN12L XCL2 CARD11 GPR171 XCL1	6.26e-07	177	123	7	e73d8e78a96b63e27a8a7694c62b3c44ec7ecfe6
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DSG2 TSHR AK8 SYTL3 DNAH9 HYDIN	6.51e-07	178	123	7	b1db59344c074c7c80169fc2c5cd5fc89f3fe463
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DSG2 TSHR AK8 SYTL3 DNAH9 HYDIN	6.51e-07	178	123	7	579cdc14f28b459e200ae2102e0bd4df8a2c0dcb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD19 ZGRF1 PAK6 SCN2A SCN3A RAD54B KIF11	7.01e-07	180	123	7	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	RA-17._Lymphocyte\|RA / Chamber and Cluster_Paper	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171 PREX1	7.55e-07	182	123	7	257a7847917b6ea1d60608183d90300bfd028758
ToppCell	CF-Lymphoid-T_cell_&_NK_cell\|CF / Disease state, Lineage and Cell class	SIDT1 SLFN12L XCL2 CARD11 GPR171 XCL1 VCAM1	7.55e-07	182	123	7	a8dfc59a3974e3433f434676b7c2749d0fcfc8b2
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MANBA ZGRF1 MPEG1 EIF2S3 CARD11 GPR171 KIF11	7.55e-07	182	123	7	57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIDT1 SLFN12L SYTL3 XCL2 CARD11 XCL1 PREX1	8.43e-07	185	123	7	45890fa81c65a48f4fdec164a4c8d0e2831243c0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIDT1 SLFN12L SYTL3 XCL2 CARD11 XCL1 PREX1	8.43e-07	185	123	7	585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZGRF1 PAK6 BRCA1 GUCY1A2 RAD54B CDH11 KIF11	9.06e-07	187	123	7	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZGRF1 PAK6 BRCA1 GUCY1A2 RAD54B CDH11 KIF11	9.06e-07	187	123	7	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	human_hepatoblastoma-NK.T_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171 PREX1	9.39e-07	188	123	7	71b7599e7e1d63cc0c8518c0501533755951d58f
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SIDT1 SLFN12L SYTL3 COBL CARD11 DNAH9 HYDIN	9.39e-07	188	123	7	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	9.72e-07	189	123	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE USP24 ABCA10 SCN2A SCN3A PKHD1 COBL	9.72e-07	189	123	7	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE ADGRB3 FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11	9.72e-07	189	123	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Severe-Lymphoid-T-NK\|Severe / Condition, Lineage, Cell class and cell subclass	SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1 KIF11	1.01e-06	190	123	7	60642de433f84fa2cecd796c3a1a4aab9219d3db
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	1.01e-06	190	123	7	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 GREB1L SUSD1 SCN2A SCN3A PKHD1 CARD11	1.04e-06	191	123	7	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	1.04e-06	191	123	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SIDT1 SLFN12L SYTL3 XCL2 CARD11 XCL1 PREX1	1.04e-06	191	123	7	5696e2e2db7b898a1c7ab3582ae74cb712dd5bdf
ToppCell	Control-Lymphoid-T_Cytotoxic\|Control / Disease state, Lineage and Cell class	SIDT1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.04e-06	191	123	7	03b5c5e0941c3402ab3f48cbf3da2a027d110421
ToppCell	COPD-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	SIDT1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.08e-06	192	123	7	5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	1.08e-06	192	123	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11 VCAM1	1.08e-06	192	123	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	COPD-Lymphoid-T_Cytotoxic\|COPD / Disease state, Lineage and Cell class	SIDT1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.12e-06	193	123	7	58e94fe2e89cdafc6974938f97a4c162061a437d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE ADGRB3 FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11	1.12e-06	193	123	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	IPF-Lymphoid\|IPF / Disease state, Lineage and Cell class	SIDT1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.12e-06	193	123	7	bf9d50aea909a28dd1d0933af33842d5f1ae7818
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 GREB1L SUSD1 SCN2A SCN3A PKHD1 CARD11	1.16e-06	194	123	7	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE ADGRB3 FREM1 ALDH1A2 GUCY1A2 LSAMP CDH11	1.16e-06	194	123	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 GREB1L SUSD1 SCN2A SCN3A PKHD1 CARD11	1.16e-06	194	123	7	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	human_hepatoblastoma-NK.T_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171 PREX1	1.16e-06	194	123	7	997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6
ToppCell	Control-Lymphoid\|Control / Disease state, Lineage and Cell class	SIDT1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.16e-06	194	123	7	d5b124f15c953eeb7e8e990df44d7fa466f2b31f
ToppCell	Adult-Immune-T_lymphocyte-D231\|Adult / Lineage, Cell type, age group and donor	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171 PREX1	1.16e-06	194	123	7	5c1dca33f382f37a7deb23e573578343c3b54986
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	COL12A1 ADGRB3 THUMPD1 ABCA10 GASK1B FREM1 ALDH1A2	1.20e-06	195	123	7	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.24e-06	196	123	7	a65d6a2d9eb3fca8faf323dbc4430e53134b7221
ToppCell	Parenchyma_Control_(B.)-Immune-TX-T_cells\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SLAMF1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.28e-06	197	123	7	3712eaa1d2ed200e0b0fdb2886f4cdf641fd2cdc
ToppCell	Lung_Parenchyma-Control-Lymphocyte-T/NK-Other_T-T_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLAMF1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.28e-06	197	123	7	7effa80fa97a97906a9e8e8d00513bebfef0f980
ToppCell	Severe_COVID-19-T/NK-NK\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	SIDT1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.28e-06	197	123	7	cc20162892b59e48653981f91fc9a0c27064444d
ToppCell	Lung_Parenchyma-Control-Lymphocyte-T/NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLAMF1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.28e-06	197	123	7	185e9a6bd9894a050604a1af66c2fc39cf1f8d7a
ToppCell	Lung_Parenchyma-Control-Lymphocyte-T/NK-Other_T-T_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLAMF1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.28e-06	197	123	7	af96ef0dbf89d4a2b78f48a1e1182b719025d67c
ToppCell	Lung_Parenchyma-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLAMF1 SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1	1.28e-06	197	123	7	6153f14a457c0b8452729aa301e5486a539e9cba
ToppCell	Mild_COVID-19-T/NK\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	SIDT1 SLAMF1 SLFN12L XCL2 CARD11 GPR171 XCL1	1.33e-06	198	123	7	329eb0fc0bda3d66765de0393290dccb3e15c311
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.37e-06	199	123	7	0486ab11f59f1ef52ddc42094f0f1e65f743a969
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.37e-06	199	123	7	28b12df9b899784bf405c5d52a0d43fd1a6c6b62
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLFN12L SYTL3 XCL2 CARD11 GPR171 XCL1 PREX1	1.37e-06	199	123	7	0d6463e368fd611a17327322413fad145f3c7f32
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.37e-06	199	123	7	c3aa72555fa3c2a0d85172682972d91fd9bb7b6a
ToppCell	Mild-Lymphoid\|Mild / Condition, Lineage, Cell class and cell subclass	SIDT1 SLAMF1 SLFN12L XCL2 CARD11 GPR171 XCL1	1.37e-06	199	123	7	5bf1bf2741ab374b1a914fc88ef805903d1941ca
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.42e-06	200	123	7	117c8154375b137e8e4453f294c083a0973a97d5
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 CARD11 GPR171 PREX1	1.42e-06	200	123	7	5f41906cf1585e09b150a84364d47c3e466dc5b7
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE ADGRB3 ABCA10 FREM1 TGM2 LSAMP CDH11	1.42e-06	200	123	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.42e-06	200	123	7	f2a97e09000801b555edde90ddef25e313e61a31
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.42e-06	200	123	7	8b8c07a16c91bd6e0d276fba1472d0d314e03416
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T-T_CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.42e-06	200	123	7	a99cb2ba4a12d81644d054d30e0d450ce3db2b76
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLAMF1 SLFN12L SYTL3 XCL2 TRBV5-1 GPR171 XCL1	1.42e-06	200	123	7	a1a4c5cbf4c009d4c09699a16e2d5b814a8751ca
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171 PREX1	1.42e-06	200	123	7	9ef322486e46e4ff05a8cbe06cf8019e996c94b3
ToppCell	facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SIDT1 ARHGEF18 SYTL3 GPR171 XCL1 PREX1	3.83e-06	150	123	6	1f83e3be3f94aefe991a3ccd292c2d11ddef858e
ToppCell	facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SIDT1 ARHGEF18 SYTL3 GPR171 XCL1 PREX1	3.83e-06	150	123	6	cd666db614bc1b43d71e8eb7bf38cae4d580be80
ToppCell	facs-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SIDT1 ARHGEF18 SYTL3 GPR171 XCL1 PREX1	3.83e-06	150	123	6	f6ed3e7b36014d1e429b255b0027d89865e1ac07
ToppCell	367C-Lymphocytic-ILC\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABCB5 SYTL3 XCL2 GPR171 XCL1 VCAM1	5.55e-06	160	123	6	f70ec054b6d51c1565e4a257cbe3c9537c0eb09f
ToppCell	facs-Lung-nan-3m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIDT1 ARHGEF18 SYTL3 GPR171 XCL1 PREX1	5.75e-06	161	123	6	ae1cee34361dde9964581cca99a29578c3b3bd99
ToppCell	facs-Lung-nan-3m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIDT1 ARHGEF18 SYTL3 GPR171 XCL1 PREX1	5.75e-06	161	123	6	33de3e8b3238fcfc66dfbf89a913a07d464d6c35
ToppCell	cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-ILC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SIDT1 SLAMF1 SLFN12L XCL2 GPR171 XCL1	5.96e-06	162	123	6	553f91eaba72bcffb733ede45418bbee39c653ab
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF587B PTPRM XCL2 CARD11 XCL1 DNAH9	6.39e-06	164	123	6	d8ecb3de6e34f5f574449e3d2f26fa0b2b7e84e8
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZGRF1 PPWD1 SYTL3 XCL2 GPR171 XCL1	7.09e-06	167	123	6	063ec29b32e40aaa138a691da3a79ee8eef0c2be
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	OR2C3 SLFN12L XCL2 CARD11 GPR171 KIF11	7.09e-06	167	123	6	ded4d6cccd3660662f12cf5a512de31d26325f1b
ToppCell	390C-Lymphocytic-ILC-ILC-2\|390C / Donor, Lineage, Cell class and subclass (all cells)	COG2 ZGRF1 SLAMF1 ZNF587B SLFN12L XCL1	7.34e-06	168	123	6	2781dd6b369427a94c5059b44b4c8f023f5f2988
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MROH2A RYR3 SCN3A PKHD1 DNAH9 HYDIN	7.59e-06	169	123	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAK6 SYTL3 CARD11 GPR171 XCL1 KIF11	8.12e-06	171	123	6	846a9acfff0bf0a9baf65dc07b7d7a9217ed6598
ToppCell	facs-Lung-nan-3m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE SIDT1 ARHGEF18 SYTL3 GPR171 XCL1	8.40e-06	172	123	6	7af0713c40ea48f1e92c859c4fc4d8f0137c4415
ToppCell	LV-17._Lymphocyte\|World / Chamber and Cluster_Paper	SIDT1 SLFN12L SYTL3 CARD11 GPR171 XCL1	8.68e-06	173	123	6	212f013ff761cbab24a537071739867c08c402a4
ToppCell	Healthy_Control-Lymphoid-NK-CD8_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	SIDT1 SLFN12L XCL2 GPR171 XCL1 VCAM1	8.97e-06	174	123	6	5dddb822fa51b4020e4d9318acacd19c726091d6
ToppCell	facs-Skin-Telogen-3m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AK8 SUSD1 CARD11 GPR171 XCL1 PREX1	9.57e-06	176	123	6	3d372c1d527fcc118d1e5809f2524fc387682472
ToppCell	facs-Skin-Telogen-3m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AK8 SUSD1 CARD11 GPR171 XCL1 PREX1	9.57e-06	176	123	6	7b3f3d9b33770edf294cee0eccaf8a46f9331461
ToppCell	facs-Skin-Telogen-3m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AK8 SUSD1 CARD11 GPR171 XCL1 PREX1	9.57e-06	176	123	6	9c0fb2c6ae84febdf7c3d4e648985f597dcffe7a
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSG2 TSHR AK8 SYTL3 DNAH9 HYDIN	9.89e-06	177	123	6	e8bb4f8ecd5e283efec966b9fc2040a6152d5551
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE GREB1L ALDH1A2 MTERF2 PKHD1 HYDIN	1.02e-05	178	123	6	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T\|normal_Lymph_Node / Location, Cell class and cell subclass	TGM5 SYTL3 XCL2 XCL1 TAP1 VCAM1	1.05e-05	179	123	6	3dc929a10381b7d86650c6cd8f354892fe1d93e7
ToppCell	Adult-Immune-T_lymphocyte-D122\|Adult / Lineage, Cell type, age group and donor	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171	1.09e-05	180	123	6	06c371d0f0c5a7b234dd143e98800e19af95a8b5
ToppCell	LV-17._Lymphocyte\|LV / Chamber and Cluster_Paper	SIDT1 SLFN12L SYTL3 CARD11 GPR171 XCL1	1.12e-05	181	123	6	81fafa69c8c240250a667a5f3b321e8be1b9a288
ToppCell	Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYTL3 XCL2 GPR171 XCL1 TAP1 VCAM1	1.16e-05	182	123	6	9d727ab84da8de33f1021b492c90d8b4c2a8ea23
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	INTS8 IGF2BP3 BRCA1 RAD54B USP48 KIF11	1.19e-05	183	123	6	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLFN12L SYTL3 XCL2 GPR171 XCL1 PREX1	1.19e-05	183	123	6	f079179f2984def91ddf0b33d7949d5ecdbd380d
ToppCell	RA-17._Lymphocyte\|World / Chamber and Cluster_Paper	SIDT1 SLAMF1 SLFN12L SYTL3 CARD11 GPR171	1.19e-05	183	123	6	6397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLFN12L SYTL3 XCL2 GPR171 XCL1 PREX1	1.19e-05	183	123	6	49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7
ToppCell	PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ABCB5 SLAMF1 SYTL3 CARD11 GPR171 XCL1	1.23e-05	184	123	6	3e9d75af578297950e469f23fb2d28393a2feef8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLAMF1 SLFN12L XCL2 CARD11 GPR171 XCL1	1.23e-05	184	123	6	6119140287ab4b88e41194bf8d6f77ae264b3b98
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLAMF1 SLFN12L XCL2 CARD11 GPR171 PREX1	1.23e-05	184	123	6	6ce9aea2c1c9098f37bdf5135b5e2192ef03b50b
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE DSG2 AK8 FREM1 DNAH9 HYDIN	1.23e-05	184	123	6	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	CTRL-Lymphoid\|CTRL / Disease state, Lineage and Cell class	SIDT1 SLAMF1 SLFN12L SCN3A CARD11 GPR171	1.23e-05	184	123	6	26fb2c4e6cb9950c27eb15428e7e74e5abb4397d
Drug	thieno[2,3-d]pyrimidine	ICAM1 TSHR VCAM1	2.82e-06	6	120	3	CID012225304
Disease	survival time	XCL2 LSAMP XCL1	4.89e-06	9	116	3	EFO_0000714
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B CLCN2 EIF2S3	4.89e-06	9	116	3	DOID:10579 (implicated_via_orthology)
Disease	cystic fibrosis (implicated_via_orthology)	ABCB5 CFTR CLCN2	4.89e-06	9	116	3	DOID:1485 (implicated_via_orthology)
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN1A SCN2A SCN3A	6.96e-06	10	116	3	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN1A SCN2A SCN3A	6.96e-06	10	116	3	DOID:0080422 (implicated_via_orthology)
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN1A SCN2A SCN3A	1.27e-05	12	116	3	DOID:0060170 (implicated_via_orthology)
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	1.53e-05	2	116	2	DOID:0060801 (implicated_via_orthology)
Disease	bronchiectasis (is_implicated_in)	CFTR TAP1	1.53e-05	2	116	2	DOID:9563 (is_implicated_in)
Disease	complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology)	TUBG2 TUBG1	1.53e-05	2	116	2	DOID:0090138 (implicated_via_orthology)
Disease	Primary Ciliary Dyskinesia	IFT122 RPGR DNAH9 HYDIN	3.55e-05	47	116	4	C4551720
Disease	Cohen syndrome (implicated_via_orthology)	VPS13C VPS13B	4.58e-05	3	116	2	DOID:0111590 (implicated_via_orthology)
Disease	blood pressure, response to thiazide, response to beta blocker	ALDH1A2 OR5H1	4.58e-05	3	116	2	EFO_0004325, EFO_0007766, EFO_0007981
Disease	anxiety disorder (implicated_via_orthology)	SCN1A SCN2A SCN3A	8.63e-05	22	116	3	DOID:2030 (implicated_via_orthology)
Disease	rheumatic myocarditis (is_marker_for)	ICAM1 VCAM1	9.15e-05	4	116	2	DOID:8481 (is_marker_for)
Disease	lymphotactin measurement	XCL2 XCL1	9.15e-05	4	116	2	EFO_0008214
Disease	congenital diaphragmatic hernia (is_implicated_in)	FREM1 ALDH1A2	9.15e-05	4	116	2	DOID:3827 (is_implicated_in)
Disease	acquired metabolic disease (implicated_via_orthology)	IGF2BP1 IGF2BP3	9.15e-05	4	116	2	DOID:0060158 (implicated_via_orthology)
Disease	pancreatitis (is_marker_for)	ICAM1 VCAM1	1.52e-04	5	116	2	DOID:4989 (is_marker_for)
Disease	Choledochal Cyst, Type I	CFTR PKHD1	1.52e-04	5	116	2	C0009439
Disease	Congenital absence of kidneys syndrome	FREM1 GREB1L	1.52e-04	5	116	2	C1609433
Disease	Choledochal Cyst, Type II	CFTR PKHD1	1.52e-04	5	116	2	C1257796
Disease	Choledochal Cyst, Type III	CFTR PKHD1	1.52e-04	5	116	2	C1257797
Disease	Choledochal Cyst, Type IV	CFTR PKHD1	1.52e-04	5	116	2	C1257798
Disease	Choledochal Cyst, Type V	CFTR PKHD1	1.52e-04	5	116	2	C1257799
Disease	Choledochal Cyst	CFTR PKHD1	1.52e-04	5	116	2	C0008340
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	2.27e-04	6	116	2	DOID:9406 (implicated_via_orthology)
Disease	glycerophosphocholine measurement	SIDT1 LSAMP	2.27e-04	6	116	2	EFO_0010489
Disease	1-dihomo-linolenoyl-GPE (20:3n3 or 6) measurement	ALDH1A2 NTAN1	2.27e-04	6	116	2	EFO_0800358
Disease	cesarean section, Self-injurious behavior	ALDH1A2 LSAMP EXOC4	2.70e-04	32	116	3	EFO_0009636, HP_0100716
Disease	Cerebral ventriculomegaly	IFT122 HYDIN	3.18e-04	7	116	2	C1531647
Disease	Seizure, Febrile, Simple	SCN1A SCN2A	3.18e-04	7	116	2	C0149886
Disease	Seizure, Febrile, Complex	SCN1A SCN2A	3.18e-04	7	116	2	C0751057
Disease	Hydrocephalus Ex-Vacuo	IFT122 HYDIN	3.18e-04	7	116	2	C0270720
Disease	Communicating Hydrocephalus	IFT122 HYDIN	3.18e-04	7	116	2	C0009451
Disease	Fetal Cerebral Ventriculomegaly	IFT122 HYDIN	3.18e-04	7	116	2	C2936718
Disease	Post-Traumatic Hydrocephalus	IFT122 HYDIN	3.18e-04	7	116	2	C0477432
Disease	Obstructive Hydrocephalus	IFT122 HYDIN	3.18e-04	7	116	2	C0549423
Disease	Kartagener Syndrome	RPGR DNAH9 HYDIN	3.53e-04	35	116	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	RPGR DNAH9 HYDIN	3.53e-04	35	116	3	C4551906
Disease	Polynesian Bronchiectasis	RPGR DNAH9 HYDIN	3.53e-04	35	116	3	C4317124
Disease	Intellectual Disability	TRIO RAB11A BRCA1 SACS EIF2S3 SCN1A SCN3A ELP2	3.98e-04	447	116	8	C3714756
Disease	Unilateral agenesis of kidney	FREM1 GREB1L	4.22e-04	8	116	2	C0266294
Disease	Congenital Hydrocephalus	IFT122 HYDIN	4.22e-04	8	116	2	C0020256
Disease	Aqueductal Stenosis	IFT122 HYDIN	4.22e-04	8	116	2	C2936786
Disease	Febrile Convulsions	SCN1A SCN2A	5.42e-04	9	116	2	C0009952
Disease	Hydrocephalus	IFT122 HYDIN	5.42e-04	9	116	2	C0020255
Disease	Autosomal Recessive Polycystic Kidney Disease	CFTR PKHD1	5.42e-04	9	116	2	C0085548
Disease	Generalized Epilepsy with Febrile Seizures Plus	SCN1A SCN2A	5.42e-04	9	116	2	C3502809
Disease	Diaphragmatic Hernia	ICAM1 CFTR VCAM1	5.66e-04	41	116	3	C0019284
Disease	retinitis pigmentosa (is_implicated_in)	IFT140 ARHGEF18 RPGR	5.66e-04	41	116	3	DOID:10584 (is_implicated_in)
Disease	Graves ophthalmopathy (is_implicated_in)	ICAM1 TSHR	6.75e-04	10	116	2	DOID:0081120 (is_implicated_in)
Disease	concentration of large LDL particles measurement	ABCA10 ALDH1A2 KPNB1	6.97e-04	44	116	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	ABCA10 ALDH1A2 KPNB1	6.97e-04	44	116	3	EFO_0022225
Disease	response to angiotensin-converting enzyme inhibitor, Cough	CYP26B1 ABCB5 VPS13B	7.94e-04	46	116	3	EFO_0005325, HP_0012735
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	GREB1L USP48	8.23e-04	11	116	2	DOID:0050564 (is_implicated_in)
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CFTR PKHD1	8.23e-04	11	116	2	DOID:0110861 (biomarker_via_orthology)
Disease	free cholesterol in small VLDL measurement	ABCA10 ALDH1A2 KPNB1	8.46e-04	47	116	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	ABCA10 ALDH1A2 KPNB1	8.46e-04	47	116	3	EFO_0022275
Disease	Mouth Diseases	CYP26B1 BRCA1	9.86e-04	12	116	2	C0026636
Disease	free cholesterol to total lipids in small HDL percentage	CPT1A ALDH1A2 NTAN1	1.07e-03	51	116	3	EFO_0022285
Disease	phospholipids in IDL measurement	ABCA10 ALDH1A2 KPNB1	1.14e-03	52	116	3	EFO_0022164
Disease	Infantile Severe Myoclonic Epilepsy	SCN1A SCN2A	1.16e-03	13	116	2	C0751122
Disease	level of Phosphatidylcholine (16:1_18:1) in blood serum	GREB1L ALDH1A2	1.16e-03	13	116	2	OBA_2045082
Disease	triglycerides to total lipids in very large VLDL percentage	CPT1A ALDH1A2 NTAN1	1.20e-03	53	116	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	CPT1A ALDH1A2 NTAN1	1.20e-03	53	116	3	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	CPT1A ALDH1A2 NTAN1	1.27e-03	54	116	3	EFO_0022244
Disease	lysophosphatidylcholine 15:0 measurement	ALDH1A2 PKHD1	1.35e-03	14	116	2	EFO_0020941
Disease	MMR-related febrile seizures	SCN1A SCN2A	1.56e-03	15	116	2	EFO_0006519
Disease	infant head circumference	IGF2BP3 PREX1	1.56e-03	15	116	2	EFO_0004577
Disease	Urticaria	ICAM1 VCAM1	1.77e-03	16	116	2	C0042109
Disease	Synostotic Posterior Plagiocephaly	FREM1 IFT122	1.77e-03	16	116	2	C1833340
Disease	Craniosynostosis, Type 1	FREM1 IFT122	1.77e-03	16	116	2	C4551902
Disease	Acrocephaly	FREM1 IFT122	1.77e-03	16	116	2	C0030044
Disease	Trigonocephaly	FREM1 IFT122	1.77e-03	16	116	2	C0265535
Disease	Scaphycephaly	FREM1 IFT122	1.77e-03	16	116	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	FREM1 IFT122	1.77e-03	16	116	2	C2931150
Disease	Metopic synostosis	FREM1 IFT122	1.77e-03	16	116	2	C1860819
Disease	Early infantile epileptic encephalopathy with suppression bursts	SCN1A SCN2A	1.77e-03	16	116	2	C0393706
Disease	Colorectal Carcinoma	ABCB5 CFTR PAK6 ABCA10 TGM2 GUCY1A2 SACS PKHD1 EXOC4	1.85e-03	702	116	9	C0009402
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	USP24 CPT1A ALDH1A2 NTAN1 KPNB1	1.88e-03	222	116	5	EFO_0008317, EFO_0020943
Disease	free cholesterol in very large HDL measurement	PON3 ALDH1A2 NTAN1	1.89e-03	62	116	3	EFO_0022273
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	USP24 CPT1A ALDH1A2 NTAN1 KPNB1	1.99e-03	225	116	5	EFO_0008317, EFO_0020947
Disease	Eye Abnormalities	FREM1 IFT122	2.00e-03	17	116	2	C0015393
Disease	Brachycephaly	FREM1 IFT122	2.00e-03	17	116	2	C0221356
Disease	Uremia	ICAM1 VCAM1	2.00e-03	17	116	2	C0041948
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	USP24 CPT1A ALDH1A2 KPNB1	2.13e-03	137	116	4	EFO_0004611, EFO_0008591
Disease	Febrile seizure (within the age range of 3 months to 6 years)	SCN1A SCN2A	2.25e-03	18	116	2	HP_0002373
Disease	level of Sphingomyelin (d34:1) in blood serum	USP24 ALDH1A2	2.25e-03	18	116	2	OBA_2045175
Disease	level of Phosphatidylcholine (15:0_18:2) in blood serum	ALDH1A2 NTAN1	2.25e-03	18	116	2	OBA_2045065
Disease	total lipids in very large HDL measurement	PON3 ALDH1A2 NTAN1	2.26e-03	66	116	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	PON3 ALDH1A2 NTAN1	2.26e-03	66	116	3	EFO_0022298
Disease	level of Sterol ester (27:1/20:3) in blood serum	USP24 NTAN1	2.51e-03	19	116	2	OBA_2045199
Disease	hydrocephalus (implicated_via_orthology)	AK8 HYDIN	2.51e-03	19	116	2	DOID:10908 (implicated_via_orthology)
Disease	cholesterol in very large HDL measurement	PON3 ALDH1A2 NTAN1	2.57e-03	69	116	3	EFO_0022229
Disease	neuritic plaque measurement	TRIO FREM1 RYR3 BCO1 SYTL3 ARHGEF2	2.62e-03	349	116	6	EFO_0006798
Disease	number of teeth measurement	IGF2BP1 IGF2BP3	2.78e-03	20	116	2	EFO_0010073
Disease	coagulation factor V measurement	PAK6 SUSD1	2.78e-03	20	116	2	EFO_0008087
Disease	Craniosynostosis	FREM1 IFT122	2.78e-03	20	116	2	C0010278
Disease	cerebellum white matter volume change measurement, age at assessment	TRHDE ADGRB3	2.78e-03	20	116	2	EFO_0008007, EFO_0021498
Disease	level of Phosphatidylcholine (16:0_18:2) in blood serum	ALDH1A2 NTAN1	2.78e-03	20	116	2	OBA_2045071

Protein segments in the cluster

Peptide	Gene	Start	Entry
YPQTQVLVVVLNRTL	TRHDE	211	Q9UKU6
ILLVTQRITKYPVLV	ARHGEF18	596	Q6ZSZ5
LDPVTYQIIRRTLKQ	CFTR	1376	P13569
VNKTILLTTLIPYLQ	ABCA10	1111	Q8WWZ4
TLRNYTVINSKIIVV	ADGRB3	776	O60242
REYSEVKTVTVKIPQ	ALDH1A2	501	O94788
KSTSVQLLQRLYDPV	ABCB5	1056	Q2M3G0
QECILLVTQRITKYP	ARHGEF2	381	Q92974
VPAVKDTVNRYLQSV	CPT1A	176	P50416
VISNPYSRKVLTTIR	DCAF6	76	Q58WW2
IPTSKYLINNRLITT	MT-ATP6	31	P00846
IVRAYNIPTRKTTIN	CC2D2B	866	Q6DHV5
ELRPTEKVVLVSNYT	RAD54B	656	Q9Y620
QTILTEIYRIVSQKQ	RAB11A	166	P62491
ITVKELVRYTLSINP	INTS8	816	Q75QN2
TAEITVYSPQQIIKV	KCTD19	386	Q17RG1
QVRNLVYTVKINPTL	MPEG1	151	Q2M385
NPIIYSLRNKQVIVS	OR5H15	286	A6NDH6
PIIYSLRNKQVIDSL	OR5H8	286	P0DN80
ILLVTQRITKYPVLV	ARHGEF28	996	Q8N1W1
YPRKTITGTVLINVE	DSG2	476	Q14126
CLVPLIQLYRKQTST	PAK6	666	Q9NQU5
IVNRYIQEIPSTLKS	IFT122	206	Q9HBG6
IQIPQVTTLDIITRY	LONP2	541	Q86WA8
TVVQYSNLPTKERLV	MGAT3	186	Q09327
QDLTLYNPERTITVK	IGF2BP1	316	Q9NZI8
TKQIDVYRSVVCPIL	KIF11	76	P52732
SYLPKIQLVIQDTLR	CYP26B1	156	Q9NR63
VDVVVYVRVQPSQIK	KIAA1109	4041	Q2LD37
LYLQRKTVPSALLVQ	AK8	106	Q96MA6
KSPLQLQTVIYRLIV	LUZP6	26	Q538Z0
PIIYSIKTKQIQRSI	OR51B4	286	Q9Y5P0
PIIYSIKTKQIRQRI	OR51G1	291	Q8NGK1
TLNPIIYTLRNQEVK	OR4K2	281	Q8NGD2
LLKVNIRTYDNSIPI	CYLC1	6	P35663
SKTILYIINPSLEVN	FREM1	1701	Q5H8C1
IVRIPYTLSQTEVIT	GPR171	241	O14626
RKYSSIPVIQGIVNE	COG8	186	Q96MW5
LNPLIYTLRNTEVKS	OR2C3	286	Q8N628
YQPQLTVARKLLSQV	GREB1L	671	Q9C091
QELTLYNPERTITVK	IGF2BP3	316	O00425
TPQIVQYRIRKLNSS	MTERF2	326	Q49AM1
YTNIIRTILKIPSSQ	OR6C74	216	A6NCV1
TRQQVPSSIKIINYK	PTPRQ	606	Q9UMZ3
NPIIYSLRNKQVTVS	OR5H1	286	A6NKK0
NIVPRTKVVYLASET	PI4K2A	206	Q9BTU6
LNIVNVVYKVTRPLA	P2RY4	281	P51582
QVYAVKTVLQRPLSL	UPF1	486	Q92900
RTKQRIQPQKTSVYI	BRCA1	166	P38398
YPSEQIIVTEKTNIL	DDA1	41	Q9BW61
TLQPNVVYITLRSKR	GASK1B	101	Q6UWH4
TVVTPLTQQEDIKLY	EXOC4	366	Q96A65
VKVYLPNKQRTVVTV	ARAF	21	P10398
IRYVTITNCSPLVVK	HYDIN	1186	Q4G0P3
TQYKKEPVTTRQVRT	KRT17	396	Q04695
VLKRLQPQTTYDITV	COL12A1	1051	Q99715
PEKSVRLVVNYLRTQ	COBL	151	O75128
SRQKQDLYLLPIVIS	CDH11	561	P55287
VIVAIPKLQTQQTYS	MANBA	251	O00462
YLVPILTQTLTKQDE	KPNB1	321	Q14974
RIQTYLQSTKPIIDL	CMPK1	151	P30085
KYSNPVAVIITQLTI	KCTD6	131	Q8NC69
VTRKVTVNVLSPRYE	ICAM1	466	P05362
TVNVLSPRYEIVIIT	ICAM1	471	P05362
YQVQVVLKRESSQPL	DNAH9	226	Q9NYC9
VLYDPLKRVVVTNLN	ELP2	41	Q6IA86
IIPISAQLKYNIEVV	EIF2S3B	221	Q2VIR3
QQTKPLTLERTINLY	NUDT21	26	O43809
ETKPVVSISRTQLVY	COG2	501	Q14746
VEQGVLKTQIPILTY	DGLUCY	391	Q7Z3D6
LTYIRVIPQVLSNLK	ERVFC1	176	P60507
TVRIKNILEEYPSVS	SACS	1461	Q9NZJ4
VVVTENLRLSLYTVP	IFT140	246	Q96RY7
TIPSYSRAQQLLLVK	CARD11	831	Q9BXL7
NKLISAVYTVVTPII	OR6B2	271	Q6IFH4
ITNLSPYTNVSVKLI	PTPRM	446	P28827
PEISTQRKVNIYNIL	MROH2A	91	A6NES4
INVSPTTYQLLKREE	GUCY1A2	656	P33402
PKVIENIRDQTISYI	RPGR	286	Q92834
ETLKYQVAPAQLVTR	SYTL3	376	Q4VX76
SVPTVRQAVKELQVY	VCAM1	206	P19320
ELQVYISPKNTVISV	VCAM1	216	P19320
TSQVYLIVQVPPKIS	LSAMP	121	Q13449
LTQIRLNPVYKAVVS	PPWD1	226	Q96BP3
PNSIKTLVDNIQRYV	PREX1	1286	Q8TCU6
RLYEQVSTPEIKVLN	SLAMF1	136	Q13291
QAVEVLLSIYPRVQK	TAP1	456	Q03518
VSTFYSILPIRQITK	PKHD1	3456	P08F94
VSYEPITTTLKRKQE	SCN3A	1886	Q9NY46
TSYSVLVIRIVQPEL	SLCO1B7	506	G3V0H7
LLYVQQRELAVTSPK	NTAN1	46	Q96AB6
NKLISVLYTVITPIL	OR6B3	271	Q8NGW1
NKVVSVLYTVIVPLL	OR6Y1	276	Q8NGX8
IRQIPNTAIVLSTYE	SLC25A33	296	Q9BSK2
VSYQPITTTLKRKQE	SCN1A	1901	P35498
TNYIRKINPQTLETL	BCO1	141	Q9HAY6
LSVYLRANVPSKVIQ	CLTCL1	476	P53675
QSLQPSLYDSIIRIK	CLCN2	546	P51788
IKVRALLVEPVINSY	TGM2	561	P21980
TTQRLPVSRIKTYTI	XCL1	36	P47992
TTQRLPVSRIKTYTI	XCL2	36	Q9UBD3
QSIKDSLQKVIPRTY	ZNF735	101	P0CB33
CKTRTVIYEIPRSQV	PDGFA	96	P04085
KLLQRITEILPQYVS	SLFN12L	231	Q6IEE8
QELQQIIITPIKAYS	SAMD4B	381	Q5PRF9
IIITPIKAYSVLQAT	SAMD4B	386	Q5PRF9
VVVQPYNSLLTLKRL	TUBG1	181	P23258
IKRIQQQTNTYIITP	MEX3A	246	A1L020
KNEYIIPITSTTRNI	RYR3	1626	Q15413
YPVLVVVRQQKEVLS	SIDT1	91	Q9NXL6
INSRRINPKISYVIS	SUSD1	316	Q6UWL2
VSYEPITTTLKRKQE	SCN2A	1891	Q99250
SLEQLYVKLIQRSSP	TEX11	151	Q8IYF3
LTKLTLYRTVIQPGI	VPS13C	1296	Q709C8
IQNVLSEKPRVSTVY	PON3	306	Q15166
VNKIITLSYPSITIN	TGM5	611	O43548
VNETTLIKYSRLPTI	RALGAPB	926	Q86X10
TPRYLIKTRGQQVTL	TRBV5-1	26	A0A578
PSKQSIYIQRETQVR	ZNF587B	66	E7ETH6
SVQSPYRSTKLVIIE	USP24	911	Q9UPU5
LIYVNTSVIRIFIPK	VPS13B	1546	Q7Z7G8
LTPTERVYVRKSIEQ	ZGRF1	1756	Q86YA3
VVVQPYNSLLTLKRL	TUBG2	181	Q9NRH3
LVYRLQTQEKPNTTV	USP48	416	Q86UV5
DLTNPQYTVVVEIIK	THUMPD1	231	Q9NXG2
NSISSYLIKPVQRIT	TRIO	1416	O75962
PSKQSIYIQRETQVR	ZNF814	66	B7Z6K7
PNISRIYVSIDVTLQ	TSHR	76	P16473
IIPISAQLKYNIEVV	EIF2S3	221	P41091